Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

BACKGROUND: Methylxanthines and leukotriene receptor antagonists (LTRA) are not a first-line medical treatment for chronic obstructive pulmonary disease (COPD) but are frequently prescribed despite limited evidence. We aimed to elucidate the real prescribing status and clinical impacts of these agen...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Chron Obstruct Pulmon Dis
Glavni autori: Lee, Jung-Kyu, Rhee, Chin Kook, Kim, Kyungjoo, Ra, Seung Won, Lee, Jae Ha, Jung, Ki-Suck, Yoo, Kwang Ha, Kim, Yoo-Il, Kim, Deog Kyeom
Format: Artigo
Jezik:Inglês
Izdano: Dove 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885559/
https://ncbi.nlm.nih.gov/pubmed/31819397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S216326
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items